cover 24.01.2017

Cover AM Isabel official kl

cover 11.2016

Cover RSC Shin 2017

AMI Alex Cover 2014 kl

Erica AdvMater Cover 2013 kl

erc ohne

Logo EXIST png

Bundesministerium für Wirtschaft und Energie Logo.svg

68. CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells

 

Linxian Li, Mark Schmitt, Alexandra Matzke-Ogi, Parvesh Wadhwani, Veronique Orian-Rousseau,and Pavel A. Levkin

 
Adv. Sci., 2017, 4, 1600202
 
 
CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to CD44v6 positive tumor cells with highly efficient anticancer and antimetastatic properties. The reported modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications.

paper 55

 file pdf

 

 

Back 

Contact

Dr. Pavel Levkin   
Build.: 341 / Office: 154 
E-Mail: levkin@kit.edu
Tel:  +49-721-608-29175

KIT Adress

Karlsruhe Institute of Technology (Campus North)
Institute of Toxicology and Genetics - Geb. 341
Hermann-von-Helmholtz-Platz 1
76344 Eggenstein-Leopoldshafen, Germany